Gremlin-1 crystal structure and inhibitory antibody
This invention relates to crystals of the human Gremlin-1 protein, and the human Gremlin-1 protein in complex with an inhibitory antibody. The invention also relates to the structure of human Gremlin-1 (on its own, or in complex with the antibody) and uses of these structures in screening for agents which modulate Gremlin-1 activity. The invention further provides antibodies which bind an allosteric inhibitory site on Gremlin-1, together with pharmaceutical compositions and medical uses of such antibodies and agents identified by the screening methods.
1. An isolated polynucleotide encoding a monoclonal anti-Gremlin-1 antibody comprising a HCDR1/HCDR2/HCDR3/LCDR1/LCDR2/LCDR3 sequence combination of SEQ ID NOs: 4/5/6/7/8/9 or SEQ ID NOs: 3/5/6/7/8/9.
2. An expression vector comprising the polynucleotide of claim 1 .
3. A host cell comprising the expression vector of claim 2 .
4. A method of producing an antibody comprising culturing the host cell of claim 3 under conditions permitting production of the antibody, and recovering the antibody produced.